Skip to content
Save up to 80% Fast & Discrete Delivery
Avodart
Quality products
Fast & Discrete Delivery
Money-back guarantee

Avodart

4.2 (3 customer reviews)
Delivery: from 4 days
Payment
24/7 Support
Active ingredient: Dutasteride

Free delivery on orders from AED 860.00, free express delivery from AED 1,290.00

256-bit SSL
Certified pharmacy
Money-back guarantee

Dutasteride, the active ingredient of Avodart, is a 5-alpha-reductase inhibitor supplied as oral capsules for men with symptomatic benign prostatic hyperplasia. It lowers dihydrotestosterone, a hormone that drives prostate growth.

Product information

Avodart contains dutasteride, a dual 5-alpha-reductase inhibitor. It blocks both type 1 and type 2 forms of the enzyme that converts testosterone into dihydrotestosterone, also called DHT. The World Health Organization ATC system places dutasteride among drugs used for benign prostatic hyperplasia, or BPH.

BPH is non-cancerous enlargement of the prostate gland. As the prostate grows, it can press on the urethra and lead to a weak stream, hesitancy, straining, frequent urination, urgency, and waking at night to urinate.

Dutasteride is most useful when prostate enlargement is a major driver of urinary symptoms, rather than bladder irritation alone. It works gradually because the prostate needs time to shrink.

Ingredients

Avodart contains dutasteride, a dual 5-alpha-reductase inhibitor. It blocks both type 1 and type 2 forms of the enzyme that converts testosterone into dihydrotestosterone, also called DHT. The World Health Organization ATC system places dutasteride among drugs used for benign prostatic hyperplasia, or BPH.

BPH is non-cancerous enlargement of the prostate gland. As the prostate grows, it can press on the urethra and lead to a weak stream, hesitancy, straining, frequent urination, urgency, and waking at night to urinate.

Dutasteride is most useful when prostate enlargement is a major driver of urinary symptoms, rather than bladder irritation alone. It works gradually because the prostate needs time to shrink.

The capsule must remain intact. Do not split, crush, chew, or open it, because damaged capsules can release dutasteride and alter how the medicine is handled.

Therapeutic indications

Avodart is used for men with symptomatic benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate. Dutasteride lowers dihydrotestosterone by inhibiting both type 1 and type 2 5-alpha-reductase, helping address prostate growth and urinary symptoms such as weak stream, hesitancy, straining, frequent urination, urgency, and waking at night to urinate.

Dosage and administration

Take Avodart capsules by mouth once daily at a consistent time. Swallow the capsule whole with water. It may be taken with or without food, and the dose differs between strengths and between users, so there is no single amount that suits everyone.

A steady daily routine matters because dutasteride has a long elimination time and works through sustained DHT suppression. Missing occasional doses is less likely to cause an abrupt loss of effect than with short-acting medicines, yet irregular use can make it harder to judge whether treatment is helping.

Common administration points include:

  • take one prescribed daily dose rather than doubling after a missed capsule;
  • swallow the capsule whole;
  • keep doses at roughly the same time each day;
  • allow time for urinary changes to develop;
  • attend scheduled prostate and PSA monitoring.
Choose a routine linked to an existing habit, such as breakfast or brushing your teeth. The best time is the one you can repeat daily without relying on memory.

A man who misses a dose should take the next scheduled dose at the usual time. Taking extra capsules to compensate does not improve prostate control and raises exposure unnecessarily.

The benefit is not immediate. Alpha-blockers relax prostate and bladder-neck muscle within days, while dutasteride changes the hormonal stimulus behind enlargement. This makes it better suited to long-term prostate management than quick symptom relief.

When not to use it

Use requires added caution in these situations:

  • liver disease, because dutasteride is metabolised in the liver;
  • use of strong CYP3A4 inhibitors, which may increase dutasteride exposure;
  • planned PSA testing or prostate-cancer monitoring;
  • unexplained urinary symptoms, blood in urine, fever, or pelvic pain;
  • a history of breast changes requiring ongoing assessment.

Examples of medicines that can affect CYP3A4 activity include ketoconazole, ritonavir, and certain macrolide antibiotics. A full medication review should include prescribed treatments, non-prescription products, and herbal preparations.

When this is not for you

Avodart is not for you if you are a woman, a child, or have had a serious allergic reaction to dutasteride or another 5-alpha-reductase inhibitor.

Pregnant women, or women who may become pregnant, must not handle leaking or damaged capsules. Dutasteride can be absorbed through the skin and may affect development of external genitalia in a male fetus.

Do not donate blood while using dutasteride and for a period after stopping it. This precaution prevents exposure of a pregnant blood recipient to the medicine.

Possible side effects

Most men tolerate Avodart without severe problems, though sexual side effects are the adverse effects most often discussed. FDA-reviewed clinical trial data list erectile dysfunction, reduced libido, ejaculation changes, and breast tenderness or enlargement among reported reactions to dutasteride [3].

Sexual side effects may include difficulty achieving or maintaining an erection, lower sexual desire, and reduced semen volume. These effects may become less troublesome with continued treatment for some men, while others find them persistent enough to reconsider treatment with their prescriber.

Other reported effects include:

  • breast tenderness, swelling, or enlargement;
  • changes in ejaculation;
  • dizziness in men also using an alpha-blocker;
  • hypersensitivity reactions such as rash, itching, hives, or swelling.

Seek urgent care for facial swelling, breathing difficulty, widespread hives, or severe swelling. A new breast lump, nipple discharge, or persistent breast pain also needs medical assessment.

Dutasteride lowers PSA values, often by about half after several months of therapy. A clinician may adjust the interpretation of PSA results, and any sustained PSA rise while taking Avodart deserves investigation even if the figure remains within a laboratory reference range.

If sexual function changes, record when the symptom started and whether it followed treatment initiation. That timeline is more useful in a consultation than trying to estimate the change from memory.

How it affects the body

DHT is a potent androgen within prostate tissue. Dutasteride reduces DHT production, which can slow further prostate growth and gradually reduce obstruction of urine flow. EMA product information describes dutasteride as suppressing serum DHT through inhibition of both 5-alpha-reductase enzyme types [1].

Key effects of dutasteride include:

  • reducing DHT concentrations;
  • decreasing prostate volume over time.

Common mistakes

  • Stopping early because the effect is not immediate. Dutasteride works through hormonal suppression and prostate shrinkage, not same-day muscle relaxation.
  • Doubling a missed dose. This does not restore a missed dose and can increase exposure.
  • Opening a capsule. The capsule formulation is designed to be swallowed whole.
  • Forgetting to mention dutasteride before PSA testing. PSA results need interpretation in the context of treatment.
  • Assuming every urinary symptom comes from BPH. Pain, fever, visible blood, or sudden retention are not symptoms to manage by simply continuing capsules.
  • Ignoring breast symptoms. Persistent tenderness, lumps, or discharge require assessment.

The medicine is intended for men with BPH-related prostate enlargement. It is not a treatment for sudden urinary retention or a substitute for investigating potentially serious urinary symptoms.

Comparison

Avodart is often considered when the prostate is enlarged and reducing its volume is a treatment priority. The American Urological Association supports 5-alpha-reductase inhibitors for men with lower urinary tract symptoms associated with demonstrable prostatic enlargement [2].

Treatment approach Main action Typical role
Dutasteride Reduces DHT and prostate volume Long-term treatment of enlarged prostate
Finasteride Reduces DHT through one enzyme type Alternative hormonal prostate-shrinking treatment
Alpha-1 blocker Relaxes prostate and bladder-neck muscle Faster improvement of urine-flow symptoms

Dutasteride and finasteride act on prostate hormones. Dutasteride blocks two enzyme forms, while finasteride blocks one. Alpha-1 blockers do not shrink the prostate; they relax smooth muscle and may be used when faster symptom relief is needed.

Combination treatment can be appropriate for some men with larger prostates and bothersome symptoms. The trade-off is a greater medicine burden and the possibility of side effects from both drug classes, including dizziness from alpha-blockers or sexual effects from 5-alpha-reductase inhibitors.

Tell the clinician arranging prostate screening that you use dutasteride. It changes PSA interpretation and can otherwise make a PSA result look falsely reassuring.

What doctors say

In urology practice, doctors usually frame Avodart as a prostate-size treatment rather than a rapid urinary-flow treatment. Men often notice the difference between these goals: an alpha-blocker may make urination easier sooner, while dutasteride targets the enlargement that causes progressive obstruction.

Clinicians also look beyond symptoms alone. Digital examination findings, PSA trends, prostate size, residual urine, repeated urinary retention, and recurrent infections help determine whether dutasteride fits the treatment plan. NICE guidance on male lower urinary tract symptoms supports assessing symptom burden alongside complications and prostate characteristics [4].

The realistic expectation is gradual improvement. A man who stops after a short trial because nocturia has not changed yet may never reach the point at which prostate-volume reduction becomes clinically meaningful.

Comparison

Avodart Current

Active ingredient: Dutasteride
0.5mg
From AED 365.50
pills
4.2 (3)

Himplasia

Active ingredient: Asparagus racemosus, Tribulus terrestris
30caps
From AED 438.60
bottles
3.9 (5)

Comparison table: Benign Prostatic Hyperplasia

Common questions

Does Avodart cause erectile dysfunction?

Erectile dysfunction is a recognised side effect of dutasteride and is listed in FDA prescribing information revised in 2022. The risk is not identical for every man, and some men do not experience any change in erections or libido. Symptoms can include reduced desire, difficulty maintaining an erection, or ejaculation changes. Persistent sexual changes should be discussed in the context of symptom benefit, prostate size, and other possible causes such as diabetes, vascular disease, stress, or other medicines. A prescriber can assess whether the symptom is related to dutasteride or another health condition.

What happens if I stop Avodart, and do I need to taper it?

Stopping dutasteride allows DHT activity to recover gradually because the medicine remains in the body for an extended period. EMA product information published in 2024 describes dutasteride as having a long half-life, so tapering is not usually required for withdrawal safety. BPH symptoms and prostate growth may return over time after treatment ends. A change in treatment should be planned around urinary symptoms, PSA monitoring, and prostate-risk factors rather than stopped casually.

What should I do if I miss an Avodart capsule?

If one capsule is missed, resume the regular once-daily schedule with the next planned dose. FDA advice for dutasteride products is not to take an extra dose to make up for a missed one. Because dutasteride acts over time, one missed capsule is unlikely to cause a sudden change in urinary symptoms. Repeated missed doses can reduce treatment consistency and make follow-up harder to interpret.

Can Avodart be combined with alpha-blockers or herbal prostate supplements?

Dutasteride may be used with an alpha-blocker when a clinician judges that both prostate shrinkage and faster symptom relief are needed. The American Urological Association’s 2023 BPH guideline supports combination therapy for selected men with enlarged prostates. Alpha-blockers can add dizziness or low-blood-pressure effects, especially when standing quickly. Herbal supplements should also be disclosed because they may complicate assessment of urinary symptoms or PSA testing even when they do not have a direct dutasteride interaction.

Can older adults use Avodart?

Avodart is commonly prescribed to older adult men because BPH becomes more frequent with age. NICE guidance, reviewed in 2015, recommends that lower urinary tract symptoms in men are assessed for complications such as retention, infection, renal impairment, and suspected cancer before long-term management is settled. Age alone does not rule out dutasteride. Older adults taking several medicines need careful review for dizziness, liver impairment, PSA interpretation, and symptoms that could reflect conditions beyond BPH.

Can I drive or operate machinery while taking Avodart?

Dutasteride is not generally associated with sedation, and EMA product information does not identify a routine restriction on driving or machinery use. Individual reactions still matter, especially if Avodart is combined with an alpha-blocker that can cause dizziness or postural blood-pressure drops. The FDA’s 2022 prescribing information also highlights that combination treatment can change the side-effect profile. Avoid hazardous tasks if dizziness, faintness, or impaired concentration occurs after starting or changing treatment.

Do you offer anonymous delivery?

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.

Sources

  1. European Medicines Agency (2024). Avodart: Summary of Product Characteristics.
  2. American Urological Association (2023). Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2023.
  3. U.S. Food and Drug Administration (2022). Avodart Prescribing Information.
  4. National Institute for Health and Care Excellence (2015). Lower Urinary Tract Symptoms in Men: Management.

Reviews: Avodart

Arjun, 35
Dubai
Three months
Verified
Rating: 5 out of 5
I took one capsule daily for three months for urinary frequency that was interrupting my work meetings. The change was gradual, but I was waking less often at night and the stream became easier to manage. I was satisfied once the improvement became consistent.
9 Nov 2026
Vikram, 51
Jebel Ali
Four months
Verified
Rating: 5 out of 5
I took one capsule daily for four months after straining more in the morning and planning trips around toilet stops. The urgency settled and I felt less pressure when starting to urinate. The improvement was not dramatic from one day to the next, but it became clear over time.
12 Oct 2026
Hamdan, 28
Ajman
Six weeks
Verified
Rating: 2.5 out of 5
I took one capsule daily for six weeks, but stopped Avodart after I noticed a marked drop in libido and difficulty maintaining an erection. The urinary symptoms were not my main issue, so the trade-off did not suit me. I discussed the reaction with my doctor before changing treatment.
27 Oct 2026
Get our free app Shop faster and track your orders 3.9 · 268 reviews Install